Quintiles opens European headquarters in UK

Wednesday, October 12, 2011 10:42 AM

Quintiles has officially opened its new European headquarters in Reading, United Kingdom, bringing together employees from each of its four disciplines.

Lord Howe, Parliamentary Under-Secretary of State for Health commented: "Having Quintiles open their European headquarters in Reading is excellent news. Their decision shows that the UK is an attractive environment for international pharmaceutical companies to invest in.”

“The Government is committed to promoting the development of new, innovative treatments for NHS patients and I look forward to seeing the results of the exciting work that Quintiles will carry out at Reading,” said Howe.

Quintiles founder, chairman and chief executive Officer Dennis Gillings, CBE, stressed the continued importance of Europe, particularly the UK, in the global market, and Quintiles’ investment in innovation and quality across the spectrum of drug development and commercialization.

Gillings said: “I am proud to extend our strategic commitment to Europe, Middle East and Africa with this regional headquarters investment.  With such a wealth of scientific, medical and commercial expertise in the UK, the move has encouraged more cross-discipline collaboration to better serve Quintiles’ customers and power them forward in the fast-morphing world of biopharma.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs